Our Partners
Video instructions
Dermalyser is a CE-marked app that provides AI-driven decision support in just seconds, by analysing a dermoscopic image captured with your smartphone.
Faster, more confident decisions at the point of care
Dermalyser delivers accurate diagnostic support in seconds, reducing waiting times and giving healthcare practitioners peace of mind
Reduce unnecessary excisions and referrals
By improving diagnostic accuracy, Dermalyser lowers the number of avoidable procedures and optimises healthcare resources across multiple levels
Proven accuracy – outperforming existing methods
Validated in clinical trials, Dermalyser reaches 95% sensitivity in melanoma detection. Significantly benefit general practit-ioners and helping general practitioners in clinical decisions
It is an exciting time in skin cancer care – AI diagnostic support, grounded in solid science and CE-marked, can not only raise the quality of care but also improve the working environment for healthcare professionals.
Sam Polesie
MD, Associate Professor, Adjunct Senior Lecturer
About us
Our purpose is to support frontline healthcare in Skin Cancer diagnosis. Dermalyser helps healthcare professionals deliver faster and more reliable skin cancer assessments, reducing uncertainty and improving outcomes for patients.
Read moreDermalyser
Dermalyser is a mobile app that gives general practitioners fast, reliable AI support for the early detection of melanoma. By simply taking an image with a smartphone and dermatoscope, doctors receive decision support in just a few seconds — helping them make quicker, more accurate assessments, reduce unnecessary referrals, and improve care for patients.
About Dermalyser